Britain's medicines regulator said on Friday it had extended approval of the COVID-19 vaccine developed by Pfizer (PFE.N) and BioNTech (22UAy.DE) so it can be used on 12- to 15-year-olds.
Published 5 years ago on Jun 5th 2021, 6:33 am
By Web Desk
"We have carefully reviewed clinical trial data in children aged 12 to 15 years and have concluded that the Pfizer/BioNTech COVID-19 vaccine is safe and effective in this age group and that the benefits of this vaccine outweigh any risk," June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency, said.
She added that it would be up to the Joint Committee on Vaccination and Immunisation to decide whether this age group would come under the vaccine deployment programme.
Courtesy: Reuters
Two US cities could soon ban one of the world’s most controversial foods
- 21 hours ago
I only bought Pokémon Legends: Z-A during Prime Day, and it’s still on sale
- a day ago
The liver transplant system tried to fix its sex bias. Did it work?
- 21 hours ago
CDF Munir reaffirms resolve to strengthen Pakistan-Russia ties
- 8 hours ago
Pakistan, Oman vow to expand bilateral cooperation in multiple fields
- 11 hours ago
Gold prices decline after one day's increase in Pakistan
- 12 hours ago
Hands-on with Amazon’s Alexa Tablet 12 Pro and its wild new matte display
- a day ago
Anthropic launches free AI security scans for open-source projects
- a day ago
National Assembly passes resolution endorsing federal govt's imposition of emergency, governor's rule in KP
- 14 hours ago
Nobel Peace Prize winner Navi Pillay blasts Trump's 'unlawful' sanctions against ICC
- 9 hours ago
Tim Cook says ‘I’m not meddling’ in the new Apple CEO’s business
- a day ago
Saudi-led coalition orders evacuation of Yemen oil facility in Sanaa ahead of operation
- a day ago
You May Like
Trending
